ILMN vs NKTR · rev $2.25B vs rev $21.0M
Illumina Inc (ILMN) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
ILMN currently screens at market cap $15.84B. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the ILMN and NKTR stock pages for the full models.
Not investment advice.